ForgingBridges| Copay Assistance Program:
Terms and Conditions

The ForgingBridges Copay Assistance Program (“Program”) is for eligible patients with commercial prescription insurance for ATTRuby™. The Program, offered by BridgeBio Pharma Inc. (“BridgeBio”), the manufacturer of ATTRuby, is not valid for patients whose prescription claims are reimbursed, in whole or in part, by any state or federal government program, including, but not limited to, Medicaid, Medicare, Medigap, Department of Defense (DoD), Veterans Affairs (VA), TRICARE, Puerto Rico Government Insurance, or any state patient or pharmaceutical assistance program. Uninsured and cash paying patients are not eligible to enroll in the Program. To participate, a patient must be a resident of the United States, Puerto Rico, or one of the U.S. Territories. With this Program, eligible patients may pay as little as $0 per month for their ATTRuby, subject to maximum benefit amounts. Certain rules and restrictions apply. Benefits under this Program may not be redeemed more than once per 28 days. Use of this Program is void where prohibited by state law. This Program is not insurance. The offer to obtain benefits from the Program may not be combined with any other coupon, free trial, discount, prescription savings card, or other offer (including, without limitation, any program offered by a third-party payer or pharmacy benefit manager, or an agent of either, that adjusts patient cost-sharing obligations). Third-party payers, pharmacy benefit managers, or the agents of either, are prohibited from assisting patients with enrolling in the Program. Any decision to enroll in the Program must be made voluntarily by the patient. This offer is not conditioned on any past, present, or future purchase, including product refills. Participating patients and their pharmacists may not seek reimbursement for all, or any part of the benefit received by the patient through this Program. Participating patients and their pharmacists may not report the receipt of Program benefits to any insurer or other third party who pays for or reimburses any part of the prescription for which Program benefits are received, as may be required by such insurer or third-party. BridgeBio reserves the right to revoke, rescind, or amend this offer without notice.

The ForgingBridges Free Trial Program (“FTP”), sponsored by BridgeBio Pharma Inc. (“BridgeBio”), the manufacturer of ATTRuby™, provides a 1-month supply of ATTRuby at no cost to patients who meet FTP eligibility requirements and who agree to the FTP terms and conditions by submitting a signed FTP start form. FTP is a free trial offer, intended solely to allow new patients to try ATTRuby and to determine with their healthcare provider whether ATTRuby is right for them. There is no obligation to continue use of ATTRuby after the free trial has been completed. To be eligible, a patient must: (1) reside in the United States or Puerto Rico; (2) have a valid prescription for ATTRuby for an FDA-approved indication; and (3) be a new patient not currently using ATTRuby and who has not previously filled a prescription for or received a sample of ATTRuby, or received ATTRuby through the FTP. ATTRuby supplied through the FTP will (i) be dispensed only by a pharmacy designated by BridgeBio; (ii) be delivered only to the patient’s home address (no P.O. boxes) and (iii) not exceed a 1-month supply. It is unlawful for any person to sell, purchase, trade, barter, or export ATTRuby supplied through the FTP or make an offer to do so. Patients, pharmacists, and prescribers may not seek reimbursement, either directly or indirectly, for ATTRuby supplied through the FTP from health insurance or any third-party payer, including Medicare, Medicaid, and commercial insurance plans. Patients must not count the value of the FTP product as an expense incurred for purposes of determining patient out-of-pocket costs under any health insurance program, including Medicare Part D True Out-of-Pocket Costs (“TrOOP”). For patients with Medicare Part D coverage, ForgingBridges will notify the patient’s Medicare Part D plan that the patient is enrolled in the FTP and will be receiving ATTRuby at no cost outside of the Medicare Part D benefit. The FTP does not provide health insurance and is not a discount, rebate, coupon, cost-sharing program, or other form of financial assistance. Obtaining ATTRuby through the FTP is not contingent on any past, present, or future purchase of ATTRuby. This offer is limited to one use per patient per lifetime and is non-transferable. To continue a patient on therapy after such one-time use, a separate prescription must be written by the healthcare provider. Use of the FTP is void where prohibited by law and where use is prohibited by the patient’s insurance provider. BridgeBio reserves the right to rescind, revoke, or amend the FTP at any time without notice.

The ForgingBridges QuickStart Program (“Program"), sponsored by BridgeBio Pharma Inc. (“BridgeBio”), the manufacturer of ATTRuby™, provides up to a 2-month supply of ATTRuby (dispensed in 28-day increments) at no cost to eligible patients with prescription insurance coverage who are prescribed ATTRuby for an FDA-approved indication, are new to therapy, and who are pursuing insurance coverage but whose insurance coverage is delayed 5 days or more. Prescribers must complete the QuickStart Program prescription on the ForgingBridges Support Program start form. Patients must meet all Program eligibility requirements. Patients must be residents of the United States or one of the U.S. Territories. The Program is not available to patients who are uninsured or where prohibited by law. Patients may be asked to reverify insurance coverage status during the course of the Program. Once coverage is approved by the patient’s insurance plan, the patient will no longer be eligible for the Program. Participating patients and their prescribers agree not to seek reimbursement for all, or any part of the free product received by the patient through this Program from health insurance or any third-party payer. Patients must not count the free product as an expense incurred for purposes of determining out-of-pocket costs for any plan, including true out-of-pocket costs (“TrOOP”) for purposes of calculating the out-of-pocket threshold for Medicare Part D plans. For patients with Medicare Part D coverage, ForgingBridges will notify the patient’s Medicare Part D plan that the patient is enrolled in the Program and will be receiving ATTRuby at no cost for up to 2 months outside of the Medicare Part D benefit. The Program does not provide health insurance, and participation in the Program does not guarantee any insurance coverage. Other limitations may apply. BridgeBio reserves the right to rescind, revoke, or amend the Program and to discontinue support at any time without notice.

The ForgingBridges Patient Assistance Program (“Program"), sponsored by BridgeBio Pharma Inc. (“BridgeBio”), the manufacturer of ATTRuby™, provides ATTRuby at no cost to eligible patients who are prescribed ATTRuby for an FDA-approved indication and cannot afford their medication. Prescribers must complete the Patient Assistance Program prescription on the ForgingBridges Support Program start form. To qualify, patients must meet Program eligibility requirements, which include, but are not limited to: (1) having no insurance or inadequate coverage for ATTRuby; (2) meeting financial criteria and undergoing income evaluation; and (3) residing in the United States or one of the U.S. territories. If you may be eligible for Medicaid, you will be required to provide documentation of a Medicaid denial before being evaluated for Program eligibility. Participation in the Program beyond one year requires re-evaluation and re-enrollment. Patients may be asked to reverify insurance coverage status during the course of the Program. Participating patients and their prescribers agree not to seek reimbursement for all, or any part of the free product received by the patient through this Program. Patients may not count the free product received through the Program as an expense incurred for purposes of determining out-of-pocket costs for any plan, including true out-of-pocket costs (“TrOOP”) for purposes of calculating the out-of-pocket threshold for Medicare Part D plans. Patients with government health insurance, including but not limited to Medicare and Medicaid, who meet the Program eligibility criteria are eligible to receive free product for the entire coverage year. For patients with Medicare Part D coverage, ForgingBridges will notify the patient’s Medicare Part D plan that the patient is enrolled in the Program and will be receiving ATTRuby at no cost outside of the Medicare Part D benefit. No purchase necessary. The Program does not provide health insurance and participation in the Program does not offer any guarantee of insurance coverage. Other limitations may apply. BridgeBio reserves the right to rescind, revoke, or amend the Program and to discontinue support at any time without notice.